Insider · CIK 0002126941
Yuling Luo
Files at ALMR (Alamar Biosciences, Inc.). First filing -, latest -.
In brief
Yuling Luo files SEC Form 4 as CEO and director at ALMR (Alamar Biosciences, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Yuling Luo has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 29 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 20, 2026 | ALMR Alamar Biosciences, Inc. | CConversion Class B Common Stock | +1,386,746 | - | - | 1,499,797 | Apr 20, 2026 |
| Apr 20, 2026 | ALMR Alamar Biosciences, Inc. | CConversion Class B Common Stock | +364,268 | - | - | 1,864,065 | Apr 20, 2026 |
| Apr 20, 2026 | ALMR Alamar Biosciences, Inc. | JOther Class B Common Stock | -1,864,065 | - | - | 0 | Apr 20, 2026 |
| Apr 20, 2026 | ALMR Alamar Biosciences, Inc. | JOther Common Stock | +1,864,065 | - | - | 1,864,065 | Apr 20, 2026 |
| Apr 20, 2026 | ALMR Alamar Biosciences, Inc. | AGrant or award Common Stock | +76,509 | $0.00 | $0 | 1,940,574 | Apr 20, 2026 |
| Apr 20, 2026 | ALMR Alamar Biosciences, Inc. | CConversion Class B Common Stockindirect: By Spouse | +1,224,152 | - | - | 1,224,152 | Apr 20, 2026 |
| Apr 20, 2026 | ALMR Alamar Biosciences, Inc. | JOther Class B Common Stockindirect: By Spouse | -1,224,152 | - | - | 0 | Apr 20, 2026 |
| Apr 20, 2026 | ALMR Alamar Biosciences, Inc. | JOther Common Stockindirect: By Spouse | +1,224,152 | - | - | 1,224,152 | Apr 20, 2026 |
| Apr 16, 2026 | ALMR Alamar Biosciences, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +341,191 | $0.00 | $0 | 341,191 | Apr 20, 2026 |
| Apr 20, 2026 | ALMR Alamar Biosciences, Inc. | CConversion Class A Common Stockderivative | -1,020,742 | $0.00 | $0 | 0 | Apr 20, 2026 |
| Apr 20, 2026 | ALMR Alamar Biosciences, Inc. | CConversion Founders Preferred Stockderivative | -366,004 | $0.00 | $0 | 0 | Apr 20, 2026 |
| Apr 20, 2026 | ALMR Alamar Biosciences, Inc. | CConversion Series A-1 Preferred Stockderivative | -880,802 | $0.00 | $0 | 0 | Apr 20, 2026 |
| Apr 20, 2026 | ALMR Alamar Biosciences, Inc. | CConversion Class A Common Stockderivativeindirect: By Spouse | -1,224,152 | $0.00 | $0 | 0 | Apr 20, 2026 |
| Apr 20, 2026 | ALMR Alamar Biosciences, Inc. | JOther Stock Option (Right to Buy)derivative | -266,311 | $0.00 | $0 | 0 | Apr 20, 2026 |
| Apr 20, 2026 | ALMR Alamar Biosciences, Inc. | JOther Stock Option (Right to Buy)derivative | +266,311 | $0.00 | $0 | 266,311 | Apr 20, 2026 |
| Apr 20, 2026 | ALMR Alamar Biosciences, Inc. | JOther Stock Option (Right to Buy)derivative | -25,310 | $0.00 | $0 | 0 | Apr 20, 2026 |
| Apr 20, 2026 | ALMR Alamar Biosciences, Inc. | JOther Stock Option (Right to Buy)derivative | +25,310 | $0.00 | $0 | 25,310 | Apr 20, 2026 |
| Apr 20, 2026 | ALMR Alamar Biosciences, Inc. | JOther Stock Option (Right to Buy)derivative | -23,986 | $0.00 | $0 | 0 | Apr 20, 2026 |
| Apr 20, 2026 | ALMR Alamar Biosciences, Inc. | JOther Stock Option (Right to Buy)derivative | +23,986 | $0.00 | $0 | 23,986 | Apr 20, 2026 |
| Apr 20, 2026 | ALMR Alamar Biosciences, Inc. | JOther Stock Option (Right to Buy)derivative | -20,023 | $0.00 | $0 | 0 | Apr 20, 2026 |
| Apr 20, 2026 | ALMR Alamar Biosciences, Inc. | JOther Stock Option (Right to Buy)derivative | +20,023 | $0.00 | $0 | 20,023 | Apr 20, 2026 |
| Apr 20, 2026 | ALMR Alamar Biosciences, Inc. | JOther Stock Option (Right to Buy)derivative | -27,700 | $0.00 | $0 | 0 | Apr 20, 2026 |
| Apr 20, 2026 | ALMR Alamar Biosciences, Inc. | JOther Stock Option (Right to Buy)derivative | +27,700 | $0.00 | $0 | 27,700 | Apr 20, 2026 |
| Apr 20, 2026 | ALMR Alamar Biosciences, Inc. | JOther Stock Option (Right to Buy)derivative | -1,033,912 | $0.00 | $0 | 0 | Apr 20, 2026 |
| Apr 20, 2026 | ALMR Alamar Biosciences, Inc. | JOther Stock Option (Right to Buy)derivative | +1,033,912 | $0.00 | $0 | 1,033,912 | Apr 20, 2026 |
| Apr 20, 2026 | ALMR Alamar Biosciences, Inc. | JOther Stock Option (Right to Buy)derivative | -37,086 | $0.00 | $0 | 0 | Apr 20, 2026 |
| Apr 20, 2026 | ALMR Alamar Biosciences, Inc. | JOther Stock Option (Right to Buy)derivative | +37,086 | $0.00 | $0 | 37,086 | Apr 20, 2026 |
| Apr 20, 2026 | ALMR Alamar Biosciences, Inc. | JOther Stock Option (Right to Buy)derivative | -42,334 | $0.00 | $0 | 0 | Apr 20, 2026 |
| Apr 20, 2026 | ALMR Alamar Biosciences, Inc. | JOther Stock Option ((Right to Buy)derivative | +42,334 | $0.00 | $0 | 42,334 | Apr 20, 2026 |
Questions about Yuling Luo
Answered from the filings on this page, as of the latest one.
Is Yuling Luo buying or selling?
Yuling Luo has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Yuling Luo's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Yuling Luo has 0.
Where does Yuling Luo file Form 4?
Yuling Luo has filed Form 4 at ALMR (Alamar Biosciences, Inc.) as Chief Executive Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.